HIT Training in the Frail Elderly. (eHIT)

September 12, 2018 updated by: University of Nottingham

Improvements in Aerobic Performance Following a Four-week Period of High Intensity Interval Training in the Elderly.

This pilot study aims to investigate whether high intensity interval training can result in rapid improvements in physical fitness amongst the frail elderly (over 70 years old). Participants will undergo a wide range of physical fitness measures followed by a four week exercise protocol. Determination of improvement will be by repeated testing of the physical measures taken for baseline. The primary outcome measure will be anaerobic threshold. There will also be a subgroup of participants who will undergo muscle biopsy and D2O ingestion to allow an insight into the mechanistic basis behind exercise training response in this age group.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Derbyshire
      • Derby, Derbyshire, United Kingdom, DE22 3DT
        • School of Graduate Entry Medicine, Royal Derby Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged over 70 years.
  • Sufficient mobility to be able to exercise on a static exercise bike.
  • Availability for the entire trial period.
  • Sufficient capacity to consent for the trial.

Exclusion Criteria:

  • Participants under the age of 70 years.

Participants with a significant past medical history of:

  • Myocardial infarction (within last 6 months)
  • Unstable Angina
  • Heart failure (NYHA class III/IV)
  • Uncontrolled Hypertension (BP>160/100)
  • Previous stroke/TIA
  • Severe respiratory disease inc. known pulmonary hypertension(>25 mmHg), Forced -Expiratory Volume in 1 second <1.5l.
  • Brittle asthma / exercise induced asthma
  • Known cerebral aneurysm or abdominal aortic aneurysm.
  • Cognitive impairment, which may reduce individuals' ability to provide informed consent.
  • Inclusion in a recent study which included any form of exercise, taking a drug or ionising radiation.

Exclusion criteria pertaining specifically to muscle biopsies:

  • Current use of anticoagulation (i.e. Warfarin/Clopidogrel/Rivaroxaban)
  • Any pre-existing clotting disorders known to the patient (i.e. haemophilia).
  • Family history of severe bleeding requiring medical intervention.
  • Any musculoskeletal deformity or skin conditions making the taking of a biopsy unsuitable as deemed by the medical practitioner taking that sample.
  • Lack of capacity to fully consent for the procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High intensity exercise training
HIT training protocol.
Supervised exercise training.
Other Names:
  • High intensity interval training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean anaerobic threshold improvement following 4 week HIT protocol.
Time Frame: 4 weeks
Measured via cardiopulmonary exercise testing (mls/kg/min and absolute value L/kg). Pre-Post testing.
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean VO2 peak improvement following 4 week HIT protocol.
Time Frame: 4 weeks
Measured via cardiopulmonary exercise testing (mls/kg/min and absolute value L/kg). Pre-Post testing.
4 weeks
Muscle protein synthesis
Time Frame: 4 weeks
Assessment of D2O evaluated muscle protein synthesis following HIT programme. Using mass spectrometry for analysis of stable isotope uptake during training program (arbitrary units).
4 weeks
Body composition
Time Frame: 4 weeks
DXA changes in body composition (lean muscle mass (%), fat mass (%) and bone density g/cm3)) following a HIT programme
4 weeks
Muscle architecture
Time Frame: 4 weeks
Ultrasound scans used to assess changes in lean muscle mass and architecture following a HIT programme (mm and % pennation angle change).
4 weeks
Feasibility
Time Frame: 4 Weeks
Determination of frail elderly patient adherence to HIT programme (number of scheduled sessions successfully completed within 28 days).
4 Weeks
Quality of life improvement
Time Frame: 4 weeks
Quality of life questionnaires to measure subjective outcomes (EQ-5D questionnaire)
4 weeks
Daily Activity Level
Time Frame: 4 weeks
Activity questionnaire to quantify habitual physical activity (IPAQ questionnaire)
4 weeks
Physical Activity Score
Time Frame: 4 weeks
Subjective assessment of physical ability (DASI questionnaire)
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John Williams, BSc MBChB FRCA PhD, Nottingham University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

October 1, 2017

Study Completion (Actual)

April 1, 2018

Study Registration Dates

First Submitted

September 21, 2015

First Submitted That Met QC Criteria

April 28, 2017

First Posted (Actual)

May 3, 2017

Study Record Updates

Last Update Posted (Actual)

September 13, 2018

Last Update Submitted That Met QC Criteria

September 12, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on HIIT Device: ergometer

Subscribe